What's Inside


Peds BMT Home
Minnesota Medical Foundation Make a Gift
Vikings Children's Fund
Children's Cancer Research Fund
OPs Administrative Center

  Home > Education > Fellowship in Pediatric Blood and Marrow Transplantation > BMT Faculty Research
 

BMT Faculty Research

Transplant Bioliogy & Therapy
Clinical Trials

BMT Faculty Research Interests
Bruce Blazar, MD – Section Chief
Professor
blaza001@umn.edu
Transplant Biology and Therapy

Brief Description of Interest:  Graft-versus-host disease, graft-versus-leukemia, and mouse/human tumor immunotherapies.

Wei Chen, MD, PhD
Associate Professor
chenw@umn.edu
Immunotherapeutics
Transplant Biology and Therapy

Brief Description of Interest:  T cell-mediated immunotherapy of leukemia and hematological malignancies. Identification of tumor-associated antigens recognized by T cells; dendritic cell-based tumor vaccines.

Keli Hippen, PhD
Assistant Professor
hippe002@umn.edu
Transplant Biology and Therapy
Immunotherapeutics

Brief Description of Interest:  Regulatory T cells for T cell tolerance and prevention of autoimmune disease.

Troy Lund, MD, PhD
Assistant Professor
lundx072@umn.edu
Transplant Biology & Therapy
Inborn Errors of Metabolism

Brief Description of Interest:  Understanding the pathophysiological processes underlying metabolic storage diseases (ALD, MLD, MPS I, etc) and improving the outcomes for metabolic storage disease hematopoietic cell transplantation

 Margaret MacMillan, MD – Clinical Director
Assistant Professor
macmi002@umn.edu
Transplant Biology and Therapy
Interventional therapeutics

Brief Description of Interest:  Clinical trials in Fanconi anemia, JMML and Acute GVHD.

Wes Miller, MD
Assistant Professor
mill4991@umn.edu
Transplant Biology & Therapy
Inborn Errors of Metabolism

Brief Description of Interest:  Improving outcomes for transplantation for metabolic disorders.

Angela Mortari, PhD
Associate Professor
panos001@umn.edu
Transplant Biology and Therapy

Brief Description of Interest:  Mechanisms responsible for GVHD & Idiopathic Pneumonia Syndrome.  Genetic and immune parameters responsible for resistance or susceptibility to malignant histiocytosis.

Paul Orchard, MD
Associate Professor
orcha001@umn.edu
Transplant Biology and Therapy
Inborn Errors of Metabolism

Brief Description of Interest: Bone marrow transplant for inborn errors of metabolism.  Phase I trials.

Angela Smith, MD, MS
Assistant Professor
smith719@umn.edu
Transplant Biology & Therapy
Clinical Trials

Brief Description of Interest:  Stem cell transplant for immunodeficiencies and hemoglobinopathies. Acute and long-term transplant related complications.

Heather Stefanski, MD, PhD
Assistant Professor
stef0030@umn.edu
Transplant Biology & Therapy

Brief Description of Interest:  Expediting immune reconstitution after transplant..

Jakub Tolar, MD, PhD
Assistant Professor
tolar003@umn.edu
Transplant Biology and Therapy
Regenerative Medicine
Bone Marrow Failure

Brief Description of Interest:  Hematopoietic and non-hematopoietic adult stem cells: basic biology, homing, and application for correction of congenital disorders or tissue injury associated with bone marrow transplantation. Non-viral gene therapy for correction of congenital disorders in vivo and ex vivo.  Clinical interests include Severe Aplastic Anemia and Dyskeratosis Congenita.

Michael Verneris, MD
Assistant Professor
verneris@umn.edu
Immunotherapeutics
Transplant Biology and Therapy

Brief Description of Interest:  The identification, characterization and expansion of innate immune effector cell populations mediating graft vs. malignancy effects (NK-T cells, gamma/delta cells and NK cells).  Mechanisms of tumor recognition, homing and cytotoxicity.

John Wagner, MD – Division Head
Professor
wagne002@umn.edu
Transplant Biology and Therapy
Co-Director, Center of Translational Medicine

Brief Description of Interest:  Umbilical cord blood transplantation; unrelated donor marrow transplantation; Fanconi anemia

Xianzheng Zhou, MD, PhD
Assistant Professor
zhoux058@umn.edu
Immunotherapeutics
Transplant Biology and Therapy

Brief Description of Interest:  Enhancement of Immunotoxicity to leukemia.

 


Feedback | Notice of Privacy Practices